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Summary.-Previous studies have shown that various amine hormones are able to
influence the growth rate of human colorectal carcinomas propagated as xenografts
in immune-deprived mice, and it is now well known that the effects of many amine
and other hormones are mediated by cyclic nucleotides, acting as second messengers
within cells. In the present study the influence of various derivatives of cyclic
adenosine monophosphate and cyclic guanosine monophosphate on the growth of
two different lines of colorectal cancer growing in immune-deprived mice, and on the
cell production rate in the colonic crypt epithelium of the rat, was assessed. Growth
of each tumour line, as well as crypt-cell production, was suppressed by treatment
with N602' dibutyryl and N6 monobutyryl derivatives of cyclic adenosine mono-
phosphate. Dibutyryl cyclic guanosine monophosphate, on the other hand, was found
to promote the growth of Tumour HXK4 and to promote crypt cell production, but
to have no significant effect on Tumour HXM2.
THERE IS MOUNTING EVIDENCE that cell
proliferation in the colonic crypt epi-
thelium and in colonic tumours is influ-
enced by amine hormones. Adrenaline
and other beta-adrenergic agonists have
been shown to inhibit cell division in
dimethylhydrazine-induced tumours of
rat colon (Tutton & Barkla, 1977a),
whereas histamine (acting via histamine-
H2 receptors) and serotonin both promote
cell division in these tumours (Tutton &
Barkla, 1978a, b; 1980a). By contrast
noradrenaline, acting via an a-adrenergic
receptor, promotes cell production in the
colonic crypt epithelium (Tutton & Barkla,
1977a; Tutton & Steel, 1979) have shown
that the growth rate of human colonic
tumours propagated as xenografts in
immune-deprived mice is also influenced
by amine hormones. Growth ofone tumour
line, HXK4, a moderately to well differen-
tiated colonic adenocarcinoma (Nowak
etal., 1978) was inhibited by the histamine-
H2-receptor antagonist, cimetidine, where-
as another colonic tumour, HXK7 (a
moderately to poorly differentiated colonic
adenocarcinoma) was inhibited by an
anti-serotoninergic drug, BW50Ic. The
growth of Tumour HXK4 was also in-
hibited by adrenaline acting through a
/3-adrenoceptor.
Cyclic nucleotides have been implicated
as intracellular mediators of the effects of
many hormones, including the biogenic
amines adrenaline, noradrenaline, hista-
mine and serotonin. The catecholamines,
such as adrenaline and noradrenaline,
have been shown to act via receptors
which were originally classified into 2
groups, of and : (Ahlquist, 1948) and which
have subsequently been sub-classified into
4 groups, (xi and 0x2 (Berthelson & Pet-
tinger, 1977), and gi and /2 (Lands et al.,
1967). The response to cxi receptors is
mediated via calcium ions, whereas that
of alpha2 receptors is mediated by inhibi-
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tion of adenylate cyclases and consequent
lowering of intracellular cyclic AMP level
(Fain & Garcia-Sainz, 1980). The response
to both types of ,B adrenoceptors is media-
ted by activation ofadenylate cyclase and
consequent elevation of cellular cyclic
AMP levels (Maguire et al., 1977). The
cellular responses to histamine are media-
ted by receptors which have been termed
HI and H2 (Ash & Schild, 1966; Black
et al., 1972) with Hi-receptor effects being
mediated by calcium ions and H2-receptor
effects being mediated by cyclic AMP
(Fain & Garcia-Sainz, 1980). The effects
of serotonin have been attributed to
raised cyclic AMP levels in some tissues
(Enjalbert et al., 1978) and to raised cyclic
GMP levels in other tissues (Goldberg &
Haddox, 1977).
The effects of amine hormones on xeno-
graft growth are not readily explained in
terms of cyclic nucleotide actions, for two
reasons. First, in Tumour Line HXK4,
adrenaline (acting through a 3-adreno-
ceptor and hence presumably cAMP-
linked) and histamine (acting through a
histamine-H2 receptor, also presumably
cAMP-linked) have opposing actions on
tumour growth rate. Secondly, growth
appears to be promoted in one tumour
line (HXK4) by a cAMP-linked agent
(histamine via H2 receptors) and in the
other line (HXK7) by an agent (serotonin)
which is possibly a cGMP-linked agent. In
an attempt to resolve these apparent
inconsistencies, the effect of various deri-
vatives of cAMP and cGMP on the
growth of a histamine-dependent line and
a serotonin-dependent line of colonic
tumours, and on cell production in the
colonic crypt epithelium, was examined.
MATERIALS AND METHODS
Estimation of the mitotic rate in the colonic
crypt epithelium.-Male Sprague-Dawley rats
were fed Clark No. 2 pellets, tap water ad
libitum, and housed at 21-24°C with artificial
light from 07:00 to 21:00 and darkness from
21:00 to 07:00. Animals were given vin-
blastine sulphate (Velbe, Elly Lilly and Co.,
Indianapolis, U.S.A.) at a dose of4 mg/kg by
13
i.p. injection at 12:00 and were killed by
decapitation between 12:45 and 16:00. This
dose of vinblastine was found, in preliminary
experiments, to be the lowest that provides
reliable metaphase arrest in the colonic
crypts. Counts of metaphase and non-
metaphase cells in histological sections in
crypts of Lieberkuhn of the descending colon
were made as previously described (Tutton &
Barkla, 1976). Allmetaphaseindices werethen
corrected for the differences in size between
metaphase and non-metaphase nuclei and
for the geometric artefact described by
Tannock (1967). Details of these correction
factors are described elsewhere.
Graphs of corrected metaphase index vs
duration of vinblastine treatment were then
constructed for each experimental group of
tissues with mitoses blocked for 0 75-4 h.
The least-squares estimate of the regression
coefficient for each of the graphs was then
calculated; this value represents the rate at
which cells enter metaphase and has the units
of mitoses/cell/h. The statistical significance
of apparent differences between regression
coefficients for different experimental groups
of tissue was then estimated by analysis of
variance (Bliss, 1967).
Initially, cell proliferation was studied in
the colonic crypts of 14 normal rats.
Additional groups of 6 rats were treated
with N602' dibutyryl, N6 monobutyryl,
02' monobutyryl and 8-bromo cyclic AMP or
N602' dibutyryl cyclic GMP, each at a dose
of 2 mg/kg injected i.p. All cyclic-nucleotide
derivatives were purchased from the Sigma
Chemical Company, St Louis, U.S.A. A fur-
ther group of 6 rats was treated with sodium
butyrate at a dose of 7 mg/kg. This dose was
used since it represents the amount of buty-
rate moiety that was contained in the highest
dose of dibutyryl cAMP.
Xenograft technique.-Male and female
CBA/lac mice were bred in our laboratory
and immune-deprived by a technique similar
to that reported by Steel et al. (1978). Mice
aged 16-20 days were thymectomized under
ketamine anaesthesia (Ketlar, 0-15 mg/kg
i.p.). After an interval of 18-21 days the mice
were injected with cytosine arabinoside
(Cytosar, the Upjohn Company) as a dose of
200 mg/kg i.p. and then subjected, 48 h later,
to 8-5 gray of whole-body irradiation from
an X-ray source at 180 keV. Pre-treatment
with Cytosar obviated the need for marrow
reconstitution that was previously necessary
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(Lammerton & Steel, 1975). Small fragments
of tumour, 2-3 mm in greatest linear dimen-
sions, were implanted in the flanks of mice
using ketamine anaesthesia. Allimplantations
were undertaken in a Biohazard Cabinet
(Clemco, Australia, Ltd.). Tumour Line
HXK4, a moderately to well differentiated
adenocarcinoma, originally described by
Nowak et al. (1978), was obtained from the
Institute of Cancer Research, Royal Marsden
Hospital (U.K.). This tumour line had pre-
viously been assessed ashistamine-dependent,
in the sense that its growth in immune-
deprived mice was inhibited by administra-
tion of the histamine-H2-receptor antagonist
Cimetidine (Tutton & Steel, 1979). Tumour
Line HXM2 was established by the authors
from a surgically resected specimen of de-
scending colon tumour. This tumour was
histologically poorly differentiated and asses-
sed as being serotonin-dependent, in the sense
that its growth was inhibited by the antisero-
toninergic drug BW501c (Tutton & Barkla,
unpublished).
Tumourmeasurement.-Starting onthe24th
to 28th day after implantation, tumours were
measured every 1 or 2 days. The greatest and
least superficial diameters were measured,
using vernier calipers, and the xenograft
volume calculated by the formula (mean
diameter)3 x 11/6. The volume of each tumour
after t days of assessment was divided by the
volume of the same tumour at the start of
assessment (Vo) to obtain the relative tumour
volume (Vt/Vo). The mean of the logarithm
ofthis quotient was then plotted as a function
oftime for each treatment group ofmice. The
relative tumour volume was calculated be-
cause inter-xenograft variations in this para-
meter arise only during treatment; the
logarithm ofthe quotient was plotted against
time because of the previously observed
linearity of log volume vs time for xenografts
(Lamerton & Steel, 1975). Tumour volume-
doubling times for control tumours were
calculated from the linear regression of log
relative tumour volume vs time. The statis-
tical significance of any apparent difference
betweentherelativevolumesofvariousgroups
of xenografts at a particular time after the
start of treatment was assessed using the
Mann-Whitney, non-parametric test for
ranked observations (Sokal & Rohlf, 1969).
The control group oftumours for Line HXK4
contained 16 xenografts and the control
group of tumours for Line HXM2 contained
17 xenografts. Each experimental group
consisted of 10-16 xenografts. Mice were
treated with N602' dibutyryl, N6 mono-
butyryl, 02' monobutyryl or 8-bromo cyclic
AMP at doses of either 2-0 or 20 mg/kg,
N602' dibutyryl cyclic GMP at doses ofeither
0-2 or 2 mg/kg, or a combination ofdibutyryl
cyclic AMP (20 mg/kg) and a phosphodiester-
ase inhibitor, papaverine HCI at a dose of
50 mg/kg (Amer & Kreighbaum, 1975). An
additional group of mice bearing Tumour
HXK4 was treated with sodium butyrate at a
dose of 7 mg/kg. All mice were treated twice
daily.
RESULTS
The influence of various cyclic nucleo-
tide derivatives and of sodium butyrate
on the colonic crypt-cell production rate
is shown in the Table.
TABLE.-The influence of cyclic-nucleotide
derivatives on colonic crypt-cell prolifera-
tion
Nil
so(
Dil
Dil
Dose
Treatment (mg/kg)
dium butyrate 7 0
butyryl cGMP 2-0
0-2
0-02
butyryl cAMP 20
2-0
0-2
N6-monobutyryl
cAMP
02'-monobutyryl
cAMP
8-Bromo cAMP
Mitotic rate-
mean + s.e.
(mitosis/
cell/h)
0-024 + 0-006
0 040 + 0 004
0-035 + 0-006
0-063 + 0-012
0 057 + 0.010
0-008 + 0-004
0 009 + 0 004
0-008 + 0-007
2-0 0-012 + 0-002
2-0 0-019 + 0-003
2-0 0-036 + 0-007
P (vs
control)
NS
NS
<0-001
< 0-01
< 0-01
< 0-01
< 0 05
<005
NS
NS
Growth curves for Tumour HXK4 are
illustrated in Figs 1, 2 and 3, and those for
HXM2 in Figs 4 and 5. Tumour HXK4
had a mean doubling time of 8-1 days and
HXM2 had a mean doubling time of 7.3
days. In each case db cAMP was seen
to inhibit xenograft growth, though in
the case of HXK4 using a dose of 20 mg/
kg, and HXM2 using a dose of 2 mg/kg,
this response was short-lived. Of the other
cAMP derivatives tested, N6 monobutyryl
cAMP was of similar effectiveness to db
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cAMP, whereas other derivatives were
marginally effective or ineffective. In
HXK4 tumours treated with db cAMP
and the phosphodiesterase inhibitor, papa-
verine HCI, growth remained inhibited
for 5 days and, in HXM2 tumours treated
with db cAMP alone at a dose of 20 mg/kg,
growth remained inhibited for 6 days,
and the mean tumour volume after 8 days
of treatment was similar to that at the
beginning of the experiment. Papaverine
alone also inhibited the growth ofTumour
HXK4, but was less effective than db
cAMP alone. Treatment with db cGMP
at a dose of 2 mg/kg had a short-term
stimulatory effect on Tumour HXK4 and
no statistically significant effect on tumour
HXM2.
0.4r a)
E
> 0-3
0
0 2 4 6 8
Days
ofa]Lo treatment frtumourvline HXKday
,control; ---, (libutyryl cGMP (2 mg/
ksg).
0 4
E
0
0
E 0-2-
0.1
0 10,~{
J0)
-01
-o-1
I
2 4 6 8
Days
FIG. 2.-Log relative tumour volume vs days
of treatment for Tumour Line HXK4;
, control; - - - -, sodium butyrate (7
mg/kg); --, dibutyryl cAMP (20 mg/kg);
, papaverine HCI (50 mg/kg); -
dibutyryl cAMP and papaverine HCI.
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FIa. 3. Log relative tumour volume vs days
of treatment for Tumour Line HXK4;
control; - ---, dibutyryl cAMP;
--,N6-monobutyryl cAMP; ___, 02'
monobutyryl cAMP;... 8-bromo cAMP.
All doses 2 mg/kg.
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FIG. 4. Log relative tumour volume vs days
of treatment for Tumour Line HXM2;
, control; ---, dibutyryl cGMP (2 mg/
kg).
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FIG. 5.- Log relative tumour v-olume vs (lays
of treatment for Tumour Line HXM12;
, control; ., dibutyryl eAMP (2-0
mg/kg); -, dlibutyryl cAMP (20 mg/kg).
DISCUSSION
The observed inhibitory effect of cAMP
derivatives on the growth of both lines
of human colonic tumour resembles the
effects of this agent on the mitotic rate in
rat primary colonic tumours (Tutton &
Barkla, 1980c) and the stimulating effect
of db cGMP on Tumour Line HXK4 also
resembles the effect of this agent on rat
tumours (Tutton & Barkla, 1980b). Since
the growth of Tumour Line HXK4 is
inhibited by cAMP derivatives and pro-
moted by cGMP derivatives, it would
appear unlikely that the previously re-
ported growth promoting effect of hista-
mine on this tumour is mediated bv
cAMP; in fact these results raise the
possibility that the effects of histamine-
H2-receptor agonism is mediated by cGMP.
The Yin Yang hypothesis (Goldberg
et al., 1974), which proposes that various
biological processes, including cell division,
are controlled by the molar ratio of cyclic
GMP to cyclic AMP, is not, however,
uniformly supported by data from our
laboratory. We have reported previously
that in the jejunal crypt epithelium sig-
nificant inhibition of cell proliferation by
db cAMP was not obtained with doses
between 0.2 and 20 mg/kg (Tutton &
Barkia, 1980c). It must be admitted that
in these experiments direct inhibition
by cAMP may have been opposed by
indirect stimulation by increased circulat-
ing levels of thyroid hormones, which
have previously been shown to promote
jejunal crypt-cell proliferation (Carriere,
1976; Tutton, 1965). Secretion of gluco-
corticoids may also be increased by treat-
ment with cAMP derivatives (Perlmutter
et al., 1971) but this would not appear to
explain the present results, since gluco-
corticoids themselves appear not to in-
fluence colonic crypt-cell proliferation,
and to promote rather than inhibit cell
proliferation in colonic tumours (Tutton
& Barkla, submitted for publication).
Clearly, the suggested role ofcyclic nucleo-
tides as intracellular mediators for the
amine hormones which appear to influence
intestinal epithelial-cell proliferation needs
to be confirmed using radioimmunoassay
and possibly quantitative immunocyto-
chemistry of cyclic nucleotides in amine-
treated and control tissues.
If cyclic GMP is a growth stimulant in
colonic tumouirs and a mitogen in both
colonic tumours and in the colonic crypt
epithelium (Tutton & Barkla, 1980b), has
the metabolism of biogenic amines and
cyclic nucleotides any relevance to the
basic biology of neoplastic change? At
present the only optimistic lead to this
question lies in the reported differences
between particulate (membrane-bound)
and soluble (cytoplasmic) forms of guany-
late cyclase in various tissues (Kimura &
Murad, 1975). Exposure of the colonic
epithelium to the carcinogen N-methyl-
nitro-nitrosoguanidine results in a shift
from particulate to soluble guanylate
cyclase (de Rubertis & Craven, 1977).
Stimulation of soluble guanylate cyclase
by biogenic amines requires the cells to
have either an amine-uptake process
or an amine-regulated calcium-gating up-
take (Fain & Garcia-Sainz, 1980). Evidence
for such an amine-uptake process in neo-
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plastic but not in normal colonic epithelial
cells has been reported; toxic analogues
of serotonin, (5,6- and 5,7-dihydroxytryp-
tamine) cause rapid cytoplasmic changes
in DMH-induced colonic tumour cells,
but not in jejunal crypt cells (Tutton &
Barkla, 1977b; 1979). The biological
significance of amine uptake by tumour
cells remains to be assessed.
Whatever differences exist between the
mechanism controlling the synthesis and
degradation ofcyclic nucleotides in normal
and malignant tissues, the fact remains
that cellular levels of cGMP are higher,
and levels of cAMP are lower in colonic
tumours than in colonic mucosa (de
Rubertis et al., 1976). In addition, plasma
and urinary levels of cyclic GMP are
raised in patients with disseminated bowel
cancer (Chawla et al., 1979) and pharmaco-
kinetic studies have shown that this in-
crease in plasma and urinary levels of
cGMP is due to a substantial increase in
its production (Murray et al., 1979). These
cyclic-nucleotide assay results, seen in the
light of our cell-kinetic results, suggest
that cyclic nucleotides may have an
exceedingly important role in controlling
tumour growth.
This work was done during the tenure of a
research grant awarded by the Anti-Cancer Council
ofVictoria. Skilled technical assistance was provided
by Fiona Christensen and Fiona McCready.
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